Literature DB >> 3088916

The management of resistant depression.

S Levine.   

Abstract

Between 10 and 30% of depressed patients, mostly bipolar, develop a therapy-resistant illness. The known causes of such chronic evolutions are discussed: misdiagnosis (underlying schizophrenia, personality disorder or dementia), drug-induced depression (neuroleptics), systemic disease (hypothyroidism, multiple sclerosis, cardiovascular or neoplastic disease etc.), or lack of efficacy (drug compliance, insufficient dosage). Remedies are suggested: adequate dosage, drug combination (Newcastle cocktail. tricyclic antidepressant + MAOI, imipramine + T3), carbamazepine in lithium-resistant cases, alprazolam, reduction in vanadium intake, sleep deprivation, psychosurgery.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088916

Source DB:  PubMed          Journal:  Acta Psychiatr Belg        ISSN: 0300-8967


  2 in total

1.  Pharmacologic management of refractory depression.

Authors:  S Chehil; S Devarajan; S M Dursun
Journal:  Can Fam Physician       Date:  2001-01       Impact factor: 3.275

2.  Cell response to a newly developed Ti-10Ta-10Nb alloy and its sputtered nanoscale coating.

Authors:  Young-Min Kim; Mong-Sook Vang; Hong-So Yang; Sang-Won Park; Hyun-Pil Lim
Journal:  J Adv Prosthodont       Date:  2009-03-31       Impact factor: 1.904

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.